HER2-enriched breast cancer is a complex disease characterized by the overexpression of the ERBB2 amplicon. While the effects of this genomic aberration on the pathology have been studied, genome-wide deregulation patterns in this subtype of cancer are also observed. A novel approach to the study of this malignant neoplasy is the use of transcriptional networks. These networks generally exhibit modular structures, which in turn may be associated to biological processes. This modular regulation of biological functions may also exhibit a hierarchical structure, with deeper levels of modular organization accounting for more specific functional regulation. In this work, we identified the most probable (maximum likelihood) model of the hierarchi...
Nuclear receptors are a class of transcriptional factors. Together with their co-regulators, they re...
Our goal in these analyses was to use genomic features from a test set of primary breast tumors to b...
Our goal in these analyses was to use genomic features from a test set of primary breast tumors to b...
HER2-enriched breast cancer is a complex disease characterized by the overexpression of the ERBB2 am...
Breast cancer is a heterogeneous and complex disease, a clear manifestation of this is its classific...
Background: Genomic, proteomic and high-throughput gene expression data, when integrated, can be use...
Many human diseases including cancer are the result of perturbations to transcriptional regulatory n...
Resumen del póster presentado al 1st Joint Meeting of the French-Portuguese-Spanish Biochemical and ...
Background: The consecutive acquisition of genetic alterations characterizes neoplastic processes. A...
Cancer is a disease of subverted regulatory pathways. In this paper, we reconstruct the regulatory n...
Multi-omic approaches are expected to deliver a broader molecular view of cancer. However, the promi...
Abstract Background Microarray technology has unveiled transcriptomic differences among tumors of va...
Transient activation of Src oncoprotein in non-Transformed, breast epithelial cells can initiate an ...
The breast cancer network constructed from 70 experimentally verified genes is found to follow hiera...
<div><p>The breast cancer network constructed from 70 experimentally verified genes is found to foll...
Nuclear receptors are a class of transcriptional factors. Together with their co-regulators, they re...
Our goal in these analyses was to use genomic features from a test set of primary breast tumors to b...
Our goal in these analyses was to use genomic features from a test set of primary breast tumors to b...
HER2-enriched breast cancer is a complex disease characterized by the overexpression of the ERBB2 am...
Breast cancer is a heterogeneous and complex disease, a clear manifestation of this is its classific...
Background: Genomic, proteomic and high-throughput gene expression data, when integrated, can be use...
Many human diseases including cancer are the result of perturbations to transcriptional regulatory n...
Resumen del póster presentado al 1st Joint Meeting of the French-Portuguese-Spanish Biochemical and ...
Background: The consecutive acquisition of genetic alterations characterizes neoplastic processes. A...
Cancer is a disease of subverted regulatory pathways. In this paper, we reconstruct the regulatory n...
Multi-omic approaches are expected to deliver a broader molecular view of cancer. However, the promi...
Abstract Background Microarray technology has unveiled transcriptomic differences among tumors of va...
Transient activation of Src oncoprotein in non-Transformed, breast epithelial cells can initiate an ...
The breast cancer network constructed from 70 experimentally verified genes is found to follow hiera...
<div><p>The breast cancer network constructed from 70 experimentally verified genes is found to foll...
Nuclear receptors are a class of transcriptional factors. Together with their co-regulators, they re...
Our goal in these analyses was to use genomic features from a test set of primary breast tumors to b...
Our goal in these analyses was to use genomic features from a test set of primary breast tumors to b...